|
Schering-Plough can get rid of the most embarrassing ailments -- runny noses, sunburned shoulders, and fungal feet. The pharmaceuticals giant makes prescription and over-the-counter (OTC) drugs, animal health products, and personal care products. Although it is best known for allergy medications Clarinex and Nasonex, the firm also specializes in anti-inflammatory, infectious disease, cancer, cardiovascular, and women's health drugs. Schering-Plough's OTC offerings include Claritin allergy pills, Afrin nasal sprays, Dr. Scholl's foot care products, and sun care line Coppertone. Its products are marketed in some 140 countries. The company has agreed to be acquired by Merck.
|
| | | Contact Information | |
Address: |
2000 Galloping Hill Rd.
Kenilworth, NJ 07033-0530
| | Phone: | 908-298-4000 | | Fax: | 908-298-7653 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 18502.00 M | | Revenue Growth (1 yr): | 45.80% | | Employees (2008): | 51,000 | | Employee Growth (1 yr): | (-7.30%) |
|
|
Key People
| | • |
Chairman and CEO:
Fred Hassan
| | • |
EVP and CFO:
Robert J. Bertolini
| | • |
VP and CIO:
Karl D. Salnoske
|
|
|
